Has Thomas Meade, MD received payments from drug or device companies?

Yes. Drug and device makers reported $411,161 in general payments to Thomas Meade, MD across 165 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Meade, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Meade, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Meade, MD

Adult Reconstructive Orthopaedic Surgery · Bethlehem, PANPI 1275525917

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $332,946 of the $411,161 with a category attached, or 81.0%. Arthrex accounts for 85.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $101,109 and has fallen 74.6% since, to $25,719 in 2025. Among adult reconstructive orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$411,161in general payments, 2019–2025

Across 165 payments — averaging $2491.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$350K
Exactech, Inc.$51K
Pacira Pharmaceuticals Incorporated$3K
Novus Surgical Solutions LLC$2K
Heron Therapeutics, Inc.$2K
Novus Surgical Consultants$612
plus $2K from 10 others

What the payments were for

Royalty or licence$332,94681%
Consulting fees$56,85314%
Speaking & faculty fees$8,8002%
Grants$450%
Travel & lodging$5,6881%
Food & beverage$4,4281%
Education$2,4001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	91	$349,872
Exactech, Inc.	32	$51,433
Pacira Pharmaceuticals Incorporated	13	$3,216
Novus Surgical Solutions LLC	2	$2,400
Heron Therapeutics, Inc.	1	$1,500
Novus Surgical Consultants	3	$612
Stryker	8	$565
Medacta USA, Inc.	5	$553
KCI USA, Inc.	2	$493
Davol Inc.	2	$126
Pacira Therapeutics, Inc.	1	$116
Arthrosurface Incorporated	1	$107
Aesculap Implant Systems, LLC	1	$61
Medical Device Business Services, Inc.	1	$50
Boston Scientific	1	$45
Coopersurgical, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$864,803
ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE REVERS$130,994
ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY TOTAL KNEE$88,845
ARTHROPLASTY INSTRUMENTS KNEE ARTHROPLASTY PATELLO FEMORAL$88,845
ARTHROPLASTY INSTRUMENTS KNEE ARTHROPLASTY TOTAL KNEE$88,845
ARTHROPLASTY INSTRUMENTS KNEE ARTHROPLASTY UNI KNEE$44,207
ARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY TOTAL KNEE$42,150
ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY PATELLO FEMORAL$42,150
ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY TOTAL KNEE$42,150
TRULIANT$40,996
ARTHROPLASTY IMPLANTS TOTAL KNEE ARTHROPLASTY TOTAL KNEE$28,846
ARTHROPLASTY IMPLANTS TOTAL KNEE ARTHROPLASTY REVISION$28,846
ARTHROPLASTY INSTRUMENTS TOTAL KNEE ARTHROPLASTY REVISION$28,846
ARTHROPLASTY INSTRUMENTS TOTAL KNEE ARTHROPLASTY TOTAL KNEE$28,846
ARTHROPLASTY INSTRUMENTS REVERS TOTAL SHOULDER UNIVERSAL GLENOID$28,846
ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY UNI KNEE$20,449
EXPAREL$2,770
HTX-011$1,500
GMK SPHERE$372
MAKO$360

How this compares

$411,161 in reported general payments places this provider in the 95th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.

See all adult reconstructive orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$528,489

Medicare patients

858

Services billed

8,587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	18	$138
Gabapentin	24	$115
Amoxicillin	23	$96

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Bethlehem

Christopher FerranteBethlehem$1K
Robert BoothPhiladelphia$15M
Javad ParviziPhiladelphia$2.8M
Kevin AnbariAllentown$344K
Christopher MelnicPhiladelphia$307K
Frank Johannes PlatePittsburgh$239K
Gary UpdegroveHershey$119K
Jonathon BrownAllentown$89K
Jeffrey SeweckePittsburgh$84K
Jeremy GebhartMeadville$29K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →